Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
The First 90 Days: US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19
Developed in collaboration with Deloitte Consulting LLP, this report examines the role that the supply chain played in delivering medicines safely and efficiently to patients during the unprecedented early days of the COVID-19 pandemic.
HDA Names Bryan Hannon to State Government Affairs; Announces Five Promotions
The Healthcare Distribution Alliance (HDA) announced the following updates to its staff.
Discussing Solutions To Address Drug Shortages
HDA recently partnered with The Hill to facilitate an event, “Keeping Pharmacy Shelves Filled: Solutions to Address Drug Shortages,” which included speakers Rep. Larry Buschon, MD (R-Ind.); Heather Zenk, President of U.S. Supply Chain, Cencora; Dr. Mark McClellan, Director, Duke-Margolis Institute for Health Policy and Former FDA Commissioner; Michael Kleinrock, Lead Research Director, IQVIA Institute for Human Data Science; and Dr. Marta Wosińska, Senior Fellow, Center on Health Policy, The Brookings Institution. HDA President and CEO Chip Davis also sat down with Joe Ruffolo, SVP and General Manager at The Hill, to discuss how the healthcare distribution industry plays a vital role in mitigating the impact of drug shortages.
Partnering in Response to COVID-19
The evolving COVID-19 “coronavirus” pandemic has upended the lives and routines of almost every American across the country. It is during these challenging times, however, that communities have shown their resolve by coming together to tackle problems and support one another.
Member Spotlight: When Distribution Is a Family Calling
While the business of pharmaceutical distribution has changed significantly over the past eight decades, HDA members like Capital Wholesale Drug Company (Capital Drug) have continued to play an essential role in providing safe and efficient healthcare delivery to trusted pharmacists and providers.